Argenx Se (ARGX) Operating Expenses (2016 - 2026)

Argenx Se (ARGX) posted Operating Expenses of -$919.0 million for Q1 2026, up 3.72% on a QoQ basis from -$954.5 million in Q4 2025, and down 37.57% year-over-year from -$1.5 billion in Q1 2025.

Argenx Se (ARGX) Operating Expenses (2016 - 2026) Analysis & Trends

Argenx Se's Operating Expenses history runs 11 years deep, the most recent figure standing at -$919.0 million for Q1 2026.

  • Quarterly Operating Expenses fell 37.57% year-over-year to -$919.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.9 billion (down 48.68% YoY) and the FY2025 annual result came in at $3.2 billion, up 40.49% from the prior year.
  • Operating Expenses was -$919.0 million for Q1 2026 at Argenx Se, up from -$954.5 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $766.1 million in Q2 2025 and bottomed at -$954.5 million in Q4 2025.
  • A 5-year average of -$341.1 million and a median of -$420.4 million in 2023 frame the typical range for Operating Expenses.
  • Annual changes were most pronounced in 2023 — Operating Expenses jumped 247.51% — and 2025, when it plunged 240.1%.
  • Argenx Se's Operating Expenses stood at -$296.5 million in 2022, then tumbled by 87.65% to -$556.5 million in 2023, then fell by 18.28% to -$658.2 million in 2024, then tumbled by 45.03% to -$954.5 million in 2025, then increased by 3.72% to -$919.0 million in 2026.
  • Business Quant data shows ARGX's Operating Expenses at -$919.0 million in Q1 2026, -$954.5 million in Q4 2025, and -$805.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -28.01 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 15.76 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.10 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.85 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 32.68 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -919.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 445.22 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 898.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -919.00 Mn
Dec 31, 2025 -954.54 Mn
Sep 30, 2025 -805.14 Mn
Jun 30, 2025 766.13 Mn
Mar 31, 2025 -668.00 Mn
Dec 31, 2024 -658.18 Mn
Sep 30, 2024 574.69 Mn
Jun 30, 2024 -534.89 Mn
Mar 31, 2024 -505.93 Mn
Dec 31, 2023 -556.46 Mn
Sep 30, 2023 -420.43 Mn
Jun 30, 2023 383.13 Mn
Mar 31, 2023 -333.62 Mn
Dec 31, 2022 -296.55 Mn
Sep 30, 2022 -355.13 Mn
Jun 30, 2022 -259.73 Mn
Mar 31, 2022 -254.21 Mn
Dec 31, 2021 -264.60 Mn
Sep 30, 2021 -220.06 Mn
Jun 30, 2021 -224.93 Mn